GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial von Leonard, R.C.F., Adamson, D.J.A., Bertelli, G., Mansi, J., Yellowlees, A., Dunlop, J., Thomas, G.A., Coleman, R.E., Anderson, R.A.

Volltext

Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™) von Leonard, R.C.F, Williams, S, Tulpule, A, Levine, A.M, Oliveros, S

Volltext

How Age Affects the Biology of Breast Cancer von Thomas, G.A, Leonard, R.C.F

Volltext

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer von Anderson, R.A., Mansi, J., Coleman, R.E., Adamson, D.J.A., Leonard, R.C.F.

Volltext

Breast Cancer in the Elderly von Thomas, G.A, Leonard, R.C.F

Volltext

A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast... von Leonard, R.C.F., Mansi, J.L., Keerie, C., Yellowlees, A., Crawford, S., Benstead, K., Matthew, R., Adamson, D., Chan, S., Grieve, R.

Volltext

5033 Secondary PROphylaxis with G-CSF has a major effect on delivered dose intensity: the results of the UK NCRI/Anglo Celtic SPROG trial for adjuvant chemotherapy of breast cancer von Leonard, R.C.F, Mansi, J, Benstead, K, Stewart, G, Yellowlees, A, Adamson, D, Chan, S, Grieve, R

Volltext

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4 von Lodge, A J, Anderson, J J, Gullick, W J, Haugk, B, Leonard, R C F, Angus, B

Volltext

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer von Fayers, P.M., Rustin, G., Wood, R., Nelstrop, A., Leonard, R.C.F., Wilkinson, P., Cruickshank, D., McAllister, E.J., Redman, C.W.E., Parker, D., Scott, I.V., Slevin, M.L., Roulston, J.E.

Volltext

A comparison of self-reported satisfaction between adolescents treated in a "teenage" unit with those treated in adult or paediatric units von Reynolds, B.C., Windebank, K.P., Leonard, R.C.F., Wallace, W.H.B.

Volltext

Letrozole as primary medical therapy for locally advanced and large operable breast cancer von DIXON, J. M, LOVE, C. D. B, BELLAMY, C. O. C, CAMERON, D. A, LEONARD, R. C. F, SMITH, H, MILLER, W. R

Volltext

Breast cancer patients use of a touch screen in the day treatment area to record toxicity, health state and quality of life - A 12 month experience von Leonard, R.C.F., Vickery, B., Povey, S.

Volltext

4. Hormone therapy for advanced breast cancer; patients' perception von Leonard, R.C.F.

Volltext

Letters to the editor von Leonard, R.C.F.

Volltext

Capecitabine named-patient programme for patients with advanced breast cancer: the UK experience von Leonard, R.C.F, Twelves, C, Breddy, J, Chaturvedi, A, Hutcheon, A, Salazar, R, Cameron, D

Volltext

HER-2 status in locally advanced breast cancer von Doran, C., Cameron, D.A., Watters, A.D., Leonard, R.C.F., Bartlett, J.M.S.

Volltext

Profiling the Breast Cancer Proteome — The New Tool of the Future? von Grassl, J., Morishita, M., Lewis, P.D., Leonard, R.C.F., Thomas, G.

Volltext

Breast cancer patients’ experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET) von Malinovszky, K.M., Cameron, D., Douglas, S., Love, C., Leonard, T., Dixon, J.M., Hopwood, P., Leonard, R.C.F.

Volltext

Chemotherapy for older women with early breast cancer von Leonard, R.C.F., Malinovszky, K.M.

Volltext

Capecitabine named-patient programme for patients with advanced breast cancer von Leonard, R.C.F, Twelves, C, Breddy, J, Chaturvedi, A, Hutcheon, A, Salazar, R, Cameron, D

Volltext